Irene Voo, MD

Specialties

Irene Voo, M.D. is a Retina Specialist — a type of ophthalmologist that specializes in diseases of the retina and vitreous, such as diabetic retinopathy, macular degeneration, retinal artery/​vein occlusions (stroke of the eye), macular holes, retinal holes/​tears/​detachments, flashes/​floaters (posterior vitreous detachment), uveitis, genetic/​hereditary retinal disorders, and examination/​treatment of any eye condition causing vision loss.

History

Established in 2007.

I have been providing medical and surgical care for patients with diseases of the retina and vitreous in Las Vegas since 2005. From 2005 until 2015, I was in a group practice then I opened my own private practice in October 2015.

There are very few female Retina Specialists in the United States and I am very fortunate to have been chosen from hundreds of applicants to train at the nation’s top eye centers: UCLA’s Jules Stein Eye Institute for residency and the Bascom Palmer Eye Institute in Miami for Vitreoretinal Fellowship.

The additional 2 years of training as a Retina Specialist, beyond the 4 years after medical school for general ophthalmologists, means my area of expertise is diagnosis and treatment of any disorder that can cause blindness/​vision loss. It is frightening to patients to lose eyesight and I make sure each patient’s experience with me is both educational and hopeful.

Meet the Business Owner

Irene V.

Business Owner

My area of expertise as a Retina Specialist is any disorder that can cause blindness/​vision loss. I believe that education about one’s condition makes a patient feel more in charge and gives power when losing vision makes a person feel powerless. Hope is the other feeling I inspire, to see the visit as a positive action partnering with me to fight vision loss. Even if the disease can’t be stopped or cured, the patient and I are a team working together to manage the loss.

Since 2003, I have been an investigator for numerous nationwide clinical trials that have resulted in revolutionary treatments for the major blinding conditions in the United States: diabetic retinopathy, macular degeneration, and retinal vein occlusions. This direct involvement in the development of medicines for blinding diseases means I am able to counsel patients about the latest available treatment options with expertise.